Cubist Systematic Strategies’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $18.2M | Buy |
657,475
+447,536
| +213% | +$12.4M | 0.08% | 125 |
|
2025
Q1 | $4.66M | Buy |
+209,939
| New | +$4.66M | 0.03% | 450 |
|
2024
Q2 | – | Sell |
-102,997
| Closed | -$2.03M | – | 2069 |
|
2024
Q1 | $2.03M | Buy |
102,997
+67,081
| +187% | +$1.32M | 0.01% | 867 |
|
2023
Q4 | $630K | Buy |
+35,916
| New | +$630K | ﹤0.01% | 1300 |
|
2023
Q3 | – | Sell |
-40,294
| Closed | -$567K | – | 2304 |
|
2023
Q2 | $567K | Buy |
+40,294
| New | +$567K | ﹤0.01% | 1362 |
|
2023
Q1 | – | Sell |
-110,620
| Closed | -$1.66M | – | 3070 |
|
2022
Q4 | $1.66M | Buy |
110,620
+58,469
| +112% | +$876K | 0.01% | 1428 |
|
2022
Q3 | $670K | Buy |
52,151
+18,236
| +54% | +$234K | ﹤0.01% | 2321 |
|
2022
Q2 | $329K | Sell |
33,915
-8,416
| -20% | -$81.6K | ﹤0.01% | 2877 |
|
2022
Q1 | $421K | Sell |
42,331
-11,629
| -22% | -$116K | ﹤0.01% | 2621 |
|
2021
Q4 | $635K | Buy |
53,960
+13,554
| +34% | +$160K | 0.01% | 2270 |
|
2021
Q3 | $460K | Buy |
40,406
+24,313
| +151% | +$277K | 0.01% | 2088 |
|
2021
Q2 | $224K | Sell |
16,093
-5,936
| -27% | -$82.6K | ﹤0.01% | 2495 |
|
2021
Q1 | $408K | Sell |
22,029
-7,724
| -26% | -$143K | 0.01% | 2074 |
|
2020
Q4 | $526K | Buy |
29,753
+5,873
| +25% | +$104K | 0.01% | 1747 |
|
2020
Q3 | $366K | Sell |
23,880
-636
| -3% | -$9.75K | 0.01% | 1910 |
|
2020
Q2 | $625K | Buy |
24,516
+9,636
| +65% | +$246K | 0.01% | 1470 |
|
2020
Q1 | $230K | Sell |
14,880
-825
| -5% | -$12.8K | 0.01% | 1653 |
|
2019
Q4 | $174K | Buy |
15,705
+15,363
| +4,492% | +$170K | ﹤0.01% | 2070 |
|
2019
Q3 | $3K | Sell |
342
-358
| -51% | -$3.14K | ﹤0.01% | 2171 |
|
2019
Q2 | $9K | Buy |
+700
| New | +$9K | ﹤0.01% | 2407 |
|
2018
Q3 | – | Sell |
-6,619
| Closed | -$115K | – | 1978 |
|
2018
Q2 | $115K | Buy |
+6,619
| New | +$115K | 0.01% | 1498 |
|